Results 221 to 230 of about 316,034 (278)
Some of the next articles are maybe not open access.

A comparison of mast cells in skin biopsies of cutaneous mastocytosis with other inflammatory dermatoses: A study of 33 cases

Journal of cutaneous pathology
Histopathologic criteria for diagnosis of cutaneous mastocytosis include 20 mast cells per high‐power field or clusters of 15 mast cells. We aimed to determine the specificity of these criteria for cutaneous mastocytosis in comparison with inflammatory ...
Margaret M Parham   +2 more
semanticscholar   +1 more source

Atypical Diffuse Cutaneous Mastocytosis

Archives of Pediatrics & Adolescent Medicine, 1972
A 19-month-old boy was found to have atypical diffuse cutaneous mastocytosis. Although severe dermographism and pressure urticaria were present from early infancy, his disease remained undiagnosed because he lacked the characteristic bullous and pigmented lesions of urticaria pigmentosa and the pebbly skin texture usually found in diffuse cutaneous ...
T, Sahihi, N B, Esterly
openaire   +2 more sources

Cutaneous mastocytosis: A dermatological perspective

Australasian Journal of Dermatology, 2020
AbstractMastocytosis is a rare disease characterised by expansion and collection of clonal mast cells in various organs including the skin, bone marrow, spleen, lymph nodes and gastrointestinal tract. The prevalence of mastocytosis has been estimated to be one in 10 000, while the estimated incidence is one per 100 000 people per year.
Di Raimondo, Cosimo   +9 more
openaire   +5 more sources

Quantifying Mast Cell and Eosinophil Cellular Density in Skin Biopsy Tissue From Adults With Maculopapular Cutaneous Mastocytosis as Compared With Urticaria and Normal Skin: A Retrospective Histopathologic Study

American journal of dermatopathology
Background: Maculopapular cutaneous mastocytosis (MPCM) is a rare disorder characterized by a pathologic accumulation of mast cells in the skin, which may or may not be accompanied by systemic mastocytosis.
Anne L King   +6 more
semanticscholar   +1 more source

Subcellular expression of CD30 in cutaneous mastocytosis—An important factor for targeted treatment

Journal of cutaneous pathology
The subcellular distribution of CD30 on mast cells and the presence of eosinophils in cutaneous mastocytosis require further investigation, especially as the cell surface expression of CD30 is critical for the therapeutic response of systemic ...
C. Mitteldorf   +4 more
semanticscholar   +1 more source

Treatment Approaches for Diffuse Cutaneous Mastocytosis in Children: Literature Review and Actual Clinical Experience

Current Pediatrics
Background. Mastocytosis is a very rare disease with various manifestations, based on abnormal clonal proliferation of mast cells in organs and tissues, such as: skin, bone marrow, lymph nodes, liver, spleen, and gastrointestinal tract. The diagnosis can
T. Valiev   +6 more
semanticscholar   +1 more source

Cutaneous mastocytosis complicating pregnancy

Obstetrics & Gynecology, 1995
Telangiectasia macularis eruptiva perstans, a rare form of cutaneous mastocytosis associated with elevated histamine excretion, has not previously been reported to complicate pregnancy.A woman presented in the late second trimester with an anaphylactoid reaction, rash, uterine contractions, and vaginal bleeding.
J G, Donahue   +2 more
openaire   +2 more sources

Cutaneous Mastocytosis – Clinical Heterogeneity

International Archives of Allergy and Immunology, 2002
Cutaneous mastocytosis (CM) encompasses several distinct patterns of disease which can be distinguished by the type of skin lesions, age of onset, familial occurrence, noncutaneous involvement, associated c-kit mutations, and prognosis. A clear distinction of the type of CM in individual patients has important implications regarding patient management ...
Hartmann, Karin, Henz, Beate M.
openaire   +3 more sources

Treatment of Cutaneous Mastocytosis

International Archives of Allergy and Immunology, 2002
Therapy of cutaneous mastocytosis is directed towards skin and systemic symptoms due to mediator release and targeted on skin lesions. Symptomatic therapy of cutaneous mastocytosis involves agents that inhibit the release of mediators or antagonize H1 and H2 receptors such as antihistamines ketodifen and Aspirin.
openaire   +2 more sources

[Cutaneous mastocytosis].

Annales de dermatologie et de venereologie, 2007
Cutaneous mastocytosis represent the most frequent form of mastocytosis, rare diseases, defined by an abnormal accumulation and proliferation of mastocytes in one or more organs. Cutaneous mastocytosis more often appear early in childhood and usually resolve spontaneously by the time of puberty.
openaire   +3 more sources

Home - About - Disclaimer - Privacy